Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
597 |
|
| Actual shortage: | 85 (14%) | |
| Anticipated shortage: | 2 (0%) | |
| Avoided shortage: | 16 (3%) | |
| Resolved: | 494 (83%) | |
Discontinuation Reports |
69 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (74%) | |
| Reversed: | 11 (16%) | |
Late reports |
53 (8%) |
|
Overdue reports |
49 (52%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2024-04-22 | 2024-05-17 | 225878 |
| VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2024-08-01 | 2025-02-11 | 234210 |
| VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-11-21 | 2019-02-13 | 67303 |
| VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-01-15 | 2019-02-13 | 72253 |
| VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-06-27 | 2019-07-06 | 87571 |
| VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-09-13 | 2019-11-14 | 93859 |
| VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-12-20 | 2020-02-06 | 101823 |
| VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-03-24 | 2020-04-21 | 109287 |
| VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2024-10-21 | 2024-12-03 | 240725 |
| VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2024-09-09 | 2025-02-11 | 236991 |
| VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2024-12-02 | 2025-01-14 | 244301 |
| ZOLMITRIPTAN | 2.5MG | TABLET | Actual shortage | 2025-04-14 | 2025-04-15 | 254997 |
| ZOLMITRIPTAN | 2.5MG | TABLET | Resolved | 2022-07-12 | 2022-09-06 | 164478 |
| ZOLMITRIPTAN | 2.5MG | TABLET | Resolved | 2024-04-10 | 2024-11-07 | 224794 |
| ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Actual shortage | 2023-07-05 | 2025-05-05 | 197629 |
| ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2023-07-18 | 2023-10-23 | 198939 |
| ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-10-01 | 2018-10-31 | 62783 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RISEDRONATE | 35MG | TABLET | Discontinued | 2024-02-28 | 2024-02-29 | 220861 |
| ROPINIROLE | 5MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4945 |
| SOLIFENACIN | 5MG | TABLET | Discontinued | 2023-09-26 | 2023-09-26 | 205215 |
| SOLIFENACIN | 10MG | TABLET | Reversed | 2024-07-24 | 2025-01-13 | 233602 |
| TERAZOSIN | 10MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151275 |
| TERAZOSIN | 1MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151278 |
| TERAZOSIN | 2MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151281 |
| TERAZOSIN | 5MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151284 |
| TRAMADOL/ACET | 325MG 37.5MG | TABLET | Discontinued | 2020-04-08 | 2020-07-07 | 111524 |